APO RESEARCH · REPORT
Diabetes Injection Pens
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Product & engineering
Understand the product.
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Selected research
Industry Growth & Trends
Global Diabetes Injection Pens Industry Growth and Trends Forecast to 2032
Market perspective
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Global Diabetes Injection Pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top four manufacturers hold a share nearly 65%.
Europe is the largest market, with a share over 40%, followed by Asia-Pacific, and North America, both have a share about 50 percent.
Read the full market overview
In terms of product, Disposable Insulin Pens is the largest segment, with a share over 70%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital and Clinic, Online Sales, etc.
Report Scope
This report provides a structured, data-driven view of the global Diabetes Injection Pens market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diabetes Injection Pens market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetes Injection Pens market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetes Injection Pens.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Diabetes Injection Pens market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diabetes Injection Pens Market by Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Diabetes Injection Pens Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Diabetes Injection Pens Segment by Application
Hospital and Clinic
Retail Pharmacy
Online Sales
Diabetes Injection Pens Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Injection Pens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetes Injection Pens and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Injection Pens.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Injection Pens manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Diabetes Injection Pens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Insulin Pens
- Disposable Insulin Pens
Applications
- Hospital and Clinic
- Retail Pharmacy
- Online Sales
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Delfu
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Diabetes Injection Pens Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Diabetes Injection Pens Sales Estimates and Forecasts (2021-2032)
- 1.3 Diabetes Injection Pens Market by Type
- 1.3.1 Reusable Insulin Pens
- 1.3.2 Disposable Insulin Pens
- 1.4 Global Diabetes Injection Pens Market Size by Type
- 1.4.1 Global Diabetes Injection Pens Market Size Overview by Type (2021-2032)
- 1.4.2 Global Diabetes Injection Pens Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Diabetes Injection Pens Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Diabetes Injection Pens Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Diabetes Injection Pens Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Diabetes Injection Pens Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Diabetes Injection Pens Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Diabetes Injection Pens Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Diabetes Injection Pens Industry Trends
- 2.2 Diabetes Injection Pens Industry Drivers
- 2.3 Diabetes Injection Pens Industry Opportunities and Challenges
- 2.4 Diabetes Injection Pens Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Diabetes Injection Pens Revenue (2021-2026)
- 3.2 Global Top Players by Diabetes Injection Pens Sales (2021-2026)
- 3.3 Global Top Players by Diabetes Injection Pens Price (2021-2026)
- 3.4 Global Diabetes Injection Pens Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Diabetes Injection Pens Major Company Production Sites & Headquarters
- 3.6 Global Diabetes Injection Pens Company, Product Type & Application
- 3.7 Global Diabetes Injection Pens Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Diabetes Injection Pens Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Diabetes Injection Pens Players Market Share by Revenue in 2025
- 3.8.3 2025 Diabetes Injection Pens Tier 1, Tier 2, and Tier 3
4 Diabetes Injection Pens Regional Status and Outlook
- 4.1 Global Diabetes Injection Pens Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Diabetes Injection Pens Historic Market Size by Region
- 4.2.1 Global Diabetes Injection Pens Sales in Volume by Region (2021-2026)
- 4.2.2 Global Diabetes Injection Pens Sales in Value by Region (2021-2026)
- 4.2.3 Global Diabetes Injection Pens Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Diabetes Injection Pens Forecasted Market Size by Region
- 4.3.1 Global Diabetes Injection Pens Sales in Volume by Region (2027-2032)
- 4.3.2 Global Diabetes Injection Pens Sales in Value by Region (2027-2032)
- 4.3.3 Global Diabetes Injection Pens Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diabetes Injection Pens by Application
- 5.1 Diabetes Injection Pens Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacy
- 5.1.3 Online Sales
- 5.2 Global Diabetes Injection Pens Market Size by Application
- 5.2.1 Global Diabetes Injection Pens Market Size Overview by Application (2021-2032)
- 5.2.2 Global Diabetes Injection Pens Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Diabetes Injection Pens Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Diabetes Injection Pens Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Diabetes Injection Pens Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Diabetes Injection Pens Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Diabetes Injection Pens Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Diabetes Injection Pens Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novo Nordisk
- 6.1.1 Novo Nordisk Company Information
- 6.1.2 Novo Nordisk Business Overview
- 6.1.3 Novo Nordisk Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novo Nordisk Diabetes Injection Pens Product Portfolio
- 6.1.5 Novo Nordisk Recent Developments
- 6.2 Eli Lilly
- 6.2.1 Eli Lilly Company Information
- 6.2.2 Eli Lilly Business Overview
- 6.2.3 Eli Lilly Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly Diabetes Injection Pens Product Portfolio
- 6.2.5 Eli Lilly Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Diabetes Injection Pens Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 BD
- 6.4.1 BD Company Information
- 6.4.2 BD Business Overview
- 6.4.3 BD Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 BD Diabetes Injection Pens Product Portfolio
- 6.4.5 BD Recent Developments
- 6.5 Ypsomed Holding
- 6.5.1 Ypsomed Holding Company Information
- 6.5.2 Ypsomed Holding Business Overview
- 6.5.3 Ypsomed Holding Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ypsomed Holding Diabetes Injection Pens Product Portfolio
- 6.5.5 Ypsomed Holding Recent Developments
- 6.6 Dongbao
- 6.6.1 Dongbao Company Information
- 6.6.2 Dongbao Business Overview
- 6.6.3 Dongbao Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Dongbao Diabetes Injection Pens Product Portfolio
- 6.6.5 Dongbao Recent Developments
- 6.7 Owen Mumford
- 6.7.1 Owen Mumford Company Information
- 6.7.2 Owen Mumford Business Overview
- 6.7.3 Owen Mumford Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Owen Mumford Diabetes Injection Pens Product Portfolio
- 6.7.5 Owen Mumford Recent Developments
- 6.8 Ganlee
- 6.8.1 Ganlee Company Information
- 6.8.2 Ganlee Business Overview
- 6.8.3 Ganlee Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ganlee Diabetes Injection Pens Product Portfolio
- 6.8.5 Ganlee Recent Developments
- 6.9 Delfu
- 6.9.1 Delfu Company Information
- 6.9.2 Delfu Business Overview
- 6.9.3 Delfu Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Delfu Diabetes Injection Pens Product Portfolio
- 6.9.5 Delfu Recent Developments
7 North America by Country
- 7.1 North America Diabetes Injection Pens Sales by Country
- 7.1.1 North America Diabetes Injection Pens Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Diabetes Injection Pens Sales by Country (2021-2026)
- 7.1.3 North America Diabetes Injection Pens Sales Forecast by Country (2027-2032)
- 7.2 North America Diabetes Injection Pens Market Size by Country
- 7.2.1 North America Diabetes Injection Pens Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Diabetes Injection Pens Market Size by Country (2021-2026)
- 7.2.3 North America Diabetes Injection Pens Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Diabetes Injection Pens Sales by Country
- 8.1.1 Europe Diabetes Injection Pens Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Diabetes Injection Pens Sales by Country (2021-2026)
- 8.1.3 Europe Diabetes Injection Pens Sales Forecast by Country (2027-2032)
- 8.2 Europe Diabetes Injection Pens Market Size by Country
- 8.2.1 Europe Diabetes Injection Pens Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Diabetes Injection Pens Market Size by Country (2021-2026)
- 8.2.3 Europe Diabetes Injection Pens Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Diabetes Injection Pens Sales by Country
- 9.1.1 Asia-Pacific Diabetes Injection Pens Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Diabetes Injection Pens Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Diabetes Injection Pens Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Diabetes Injection Pens Market Size by Country
- 9.2.1 Asia-Pacific Diabetes Injection Pens Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Diabetes Injection Pens Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Diabetes Injection Pens Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Diabetes Injection Pens Sales by Country
- 10.1.1 South America Diabetes Injection Pens Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Diabetes Injection Pens Sales by Country (2021-2026)
- 10.1.3 South America Diabetes Injection Pens Sales Forecast by Country (2027-2032)
- 10.2 South America Diabetes Injection Pens Market Size by Country
- 10.2.1 South America Diabetes Injection Pens Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Diabetes Injection Pens Market Size by Country (2021-2026)
- 10.2.3 South America Diabetes Injection Pens Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Diabetes Injection Pens Sales by Country
- 11.1.1 Middle East and Africa Diabetes Injection Pens Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Diabetes Injection Pens Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Diabetes Injection Pens Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Diabetes Injection Pens Market Size by Country
- 11.2.1 Middle East and Africa Diabetes Injection Pens Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Diabetes Injection Pens Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Diabetes Injection Pens Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Diabetes Injection Pens Value Chain Analysis
- 12.1.1 Diabetes Injection Pens Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Diabetes Injection Pens Production Mode & Process
- 12.2 Diabetes Injection Pens Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Diabetes Injection Pens Distributors
- 12.2.3 Diabetes Injection Pens Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst